We showed that a high expression of ODAD2 downregulated the expression of NF-κB-dependent genes, dramatically reduced NF-κB activity, cellular proliferation, anchorage-independent growth, and migratory ability in vitro, and significantly decreased xenograft tumor growth in vivo. The gene discussed is NFKB1; the disease is neoplasm.